Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Dept Of Ophthalmology, |
RCV003891067 | SCV004707537 | likely pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV005101478 | SCV005741468 | pathogenic | not provided | 2024-03-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser1117Alafs*46) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EYS-related conditions. For these reasons, this variant has been classified as Pathogenic. |